Nadeem SarwarSenior Director, Worldwide Clinical Research Pfizer
Oscar PuigBiomarker & Experimental Medicine Leader Roche
Birgit FunkeDirector, Clinical R&D Laboratory for Molecular Medicine Harvard Medical School
Shashikant KulkarniHead, Clinical Genomics Washington University School of Medicine
They say that in five years time, all clinical research in areas such as oncology will be NGS based. Clinically actionable patient data will be generated at a previously unimaginable pace. It is already starting to permeate important parts of patient care and ripple throughout the entire global healthcare system.
The questions on everyone’s lips are how can information generated from advanced genomic profiling technology be turned into something clinically actionable?
And finally, extensive opportunities for networking. The unique format of Clinical Genomics 2014: interactive workshops, speed networking and round table discussions allow you to maximize your exposure and make the most of your time spent with the brightest minds in the clinical genomics space.
Whether you are already implementing genomic medicine in the clinic, or it is a near-future venture for your lab, Clinical Genomics 2014 is next year’s meeting that you have to budget for. You know this is the direction things are moving, for pharma, academia, clinicians and ultimately the physician. Surely it’s important to keep up?